T. Rowe Price Associates’s CG Oncology CGON Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $52.4M | Buy |
2,013,690
+999,094
| +98% | +$26M | 0.01% | 724 |
|
|
2025
Q1 | $24.8M | Buy |
1,014,596
+69,402
| +7% | +$1.7M | ﹤0.01% | 897 |
|
|
2024
Q4 | $27.1M | Buy |
945,194
+353,787
| +60% | +$10.1M | ﹤0.01% | 915 |
|
|
2024
Q3 | $22.3M | Sell |
591,407
-73,738
| -11% | -$2.78M | ﹤0.01% | 972 |
|
|
2024
Q2 | $21M | Sell |
665,145
-326,973
| -33% | -$10.3M | ﹤0.01% | 955 |
|
|
2024
Q1 | $43.6M | Buy |
+992,118
| New | +$43.6M | 0.01% | 765 |
|